A floor-standing shockwave platform, indicated across eleven separate conditions, each with its own IFU-defined patient population.
MoreNova also publishes alopecia areata as a therapeutic area, though it sits outside the eleven indications listed in the IFU's section 8.2; DNA Nexus attributes that claim to the manufacturer only.
Erectile dysfunction: Males above 18. Vasculogenic ED, not psychological. Duration 6 months to 7 years. IIEF-6 score 11-25. Prescribed by a physician.Peyronie's disease: MaleChronic pelvic pain syndrome / LUTS: Males aged 18-70. Symptoms 3 months or more. CPPS Category IIIA/IIIB confirmed by a urologist. NIH-CPSI score above 15.Female sexual dysfunction: Females aged 20-70. Diagnosed FSAD or HSDD. Symptoms 6 months or more.Stress urinary incontinence: Females aged 20-75. Diagnosed by physical exam and urodynamic testing. Symptoms 3 months or more.Vulvodynia: Females aged 18-70Vaginal atrophy / genitourinary syndrome of menopause: Females aged 40-75, postmenopausalWound healing: AdultsPeripheral arterial disease: AdultsCellulite: AdultsMusculoskeletal disorders: AdultsFrom erectile dysfunction to wound healing, each indication carries its own population criteria defined in MoreNova's IFU, section 8.2.
MoreNova PRO is the platform version of the range; the same indications are also available on the portable MoreNova DT.
Eleven, each with its own patient population defined in MoreNova's IFU, section 8.2.
Yes. Population per IFU section 8.2.7: "Females aged 20-75. Diagnosed by physical exam and urodynamic testing. Symptoms 3 months or more."
MoreNova publishes alopecia areata as a therapeutic area, though it is not one of the eleven indications listed in its IFU. DNA Nexus attributes that specific claim to the manufacturer.
The same indications. PRO is a floor-standing platform; DT is a portable desktop unit.
Single-use transducer covers and ultrasound coupling gel, to the manufacturer's stated specification.
DNA Nexus will handle installation and set up MoreNova PRO on site. After-sales technical support runs from Cairo, alongside the rest of the DNA Nexus shockwave portfolio.
MoreNova PRO
